• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

γ 逆转录病毒载体:生物学、技术与应用。

Gammaretroviral vectors: biology, technology and application.

机构信息

Department of Experimental Hematology, Hannover Medical School, OE6960-HBZ, Carl-Neuberg-Strasse 1, D-30625 Hannover, Germany.

出版信息

Viruses. 2011 Jun;3(6):677-713. doi: 10.3390/v3060677. Epub 2011 Jun 3.

DOI:10.3390/v3060677
PMID:21994751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3185771/
Abstract

Retroviruses are evolutionary optimized gene carriers that have naturally adapted to their hosts to efficiently deliver their nucleic acids into the target cell chromatin, thereby overcoming natural cellular barriers. Here we will review-starting with a deeper look into retroviral biology-how Murine Leukemia Virus (MLV), a simple gammaretrovirus, can be converted into an efficient vehicle of genetic therapeutics. Furthermore, we will describe how more rational vector backbones can be designed and how these so-called self-inactivating vectors can be pseudotyped and produced. Finally, we will provide an overview on existing clinical trials and how biosafety can be improved.

摘要

逆转录病毒是进化优化的基因载体,它们已经自然适应了宿主,能够有效地将其核酸递送到靶细胞染色质中,从而克服了天然的细胞屏障。在这里,我们将回顾——从深入了解逆转录病毒生物学开始——如何将简单的γ逆转录病毒鼠白血病病毒(MLV)转化为有效的基因治疗载体。此外,我们将描述如何设计更合理的载体骨架,以及如何对这些所谓的自我失活载体进行假型化和生产。最后,我们将概述现有的临床试验以及如何提高生物安全性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f365/3185771/9757c39a5875/viruses-03-00677f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f365/3185771/6ea5647e394e/viruses-03-00677f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f365/3185771/f8bffbd41fd3/viruses-03-00677f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f365/3185771/bff6aaea1aa7/viruses-03-00677f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f365/3185771/9ff5af63d936/viruses-03-00677f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f365/3185771/9757c39a5875/viruses-03-00677f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f365/3185771/6ea5647e394e/viruses-03-00677f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f365/3185771/f8bffbd41fd3/viruses-03-00677f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f365/3185771/bff6aaea1aa7/viruses-03-00677f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f365/3185771/9ff5af63d936/viruses-03-00677f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f365/3185771/9757c39a5875/viruses-03-00677f5.jpg

相似文献

1
Gammaretroviral vectors: biology, technology and application.γ 逆转录病毒载体:生物学、技术与应用。
Viruses. 2011 Jun;3(6):677-713. doi: 10.3390/v3060677. Epub 2011 Jun 3.
2
Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells.内源性逆转录病毒序列在由鼠类和人类包装细胞产生的逆转录病毒载体中的包装。
J Virol. 1998 Apr;72(4):2671-6. doi: 10.1128/JVI.72.4.2671-2676.1998.
3
Rapid establishment of stable retroviral packaging cells and recombinant susceptible target cell lines employing novel transposon vectors derived from Sleeping Beauty.利用新型源自睡美人的转座子载体快速建立稳定的逆转录病毒包装细胞和重组易感靶细胞系。
Virology. 2019 May;531:40-47. doi: 10.1016/j.virol.2019.02.014. Epub 2019 Feb 23.
4
Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells.γ逆转录病毒载体和慢病毒自我失活(SIN)载体在造血细胞中表达O6-甲基鸟嘌呤-DNA甲基转移酶的效力相同。
Mol Ther. 2006 Feb;13(2):391-400. doi: 10.1016/j.ymthe.2005.08.012. Epub 2005 Oct 12.
5
Differences in the internalization of self-inactivating VSVG-pseudotyped murine leukemia virus-based vectors in human and murine cells.人源和鼠源细胞内化自我失活 VSVG 假型鼠白血病病毒载体的差异。
J Virol Methods. 2018 May;255:14-22. doi: 10.1016/j.jviromet.2018.02.005. Epub 2018 Feb 6.
6
Enhancers are major targets for murine leukemia virus vector integration.增强子是鼠白血病病毒载体整合的主要靶点。
J Virol. 2014 Apr;88(8):4504-13. doi: 10.1128/JVI.00011-14. Epub 2014 Feb 5.
7
Efficient gene transfer of VSV-G pseudotyped retroviral vector to human brain tumor.水疱性口炎病毒糖蛋白(VSV-G)假型逆转录病毒载体向人脑肿瘤的高效基因转移
Gene Ther. 2001 Feb;8(4):268-73. doi: 10.1038/sj.gt.3301390.
8
Inhibition of histone deacetylation in 293GPG packaging cell line improves the production of self-inactivating MLV-derived retroviral vectors.在293GPG包装细胞系中抑制组蛋白去乙酰化可提高自失活莫洛尼鼠白血病病毒衍生逆转录病毒载体的产量。
Virol J. 2006 Apr 7;3:27. doi: 10.1186/1743-422X-3-27.
9
Kinetic analyses of stability of simple and complex retroviral vectors.简单和复杂逆转录病毒载体稳定性的动力学分析
Virology. 2001 Feb 1;280(1):124-31. doi: 10.1006/viro.2000.0743.
10
Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells.灵长类动物再增殖细胞中源自HIV的慢病毒载体和基于MLV的γ-逆转录病毒载体整合位点的比较。
Mol Ther. 2007 Jul;15(7):1356-65. doi: 10.1038/sj.mt.6300159. Epub 2007 Apr 17.

引用本文的文献

1
Exploring the Use of Viral Vectors Pseudotyped with Viral Glycoproteins as Tools to Study Antibody-Mediated Neutralizing Activity.探索用病毒糖蛋白假型化的病毒载体作为研究抗体介导中和活性工具的应用。
Microorganisms. 2025 Jul 31;13(8):1785. doi: 10.3390/microorganisms13081785.
2
Clinical hematopoietic stem cell-based gene therapy.基于临床造血干细胞的基因治疗。
Mol Ther. 2025 Jun 4;33(6):2663-2678. doi: 10.1016/j.ymthe.2025.04.029. Epub 2025 Apr 24.
3
The design of retroviral vectors used in the CAR-T products, risk management, and future perspective.

本文引用的文献

1
The inside out of lentiviral vectors.慢病毒载体的内部结构。
Viruses. 2011 Feb;3(2):132-159. doi: 10.3390/v3020132. Epub 2011 Feb 14.
2
Foamy virus biology and its application for vector development.泡沫病毒生物学及其在载体开发中的应用。
Viruses. 2011 May;3(5):561-85. doi: 10.3390/v3050561. Epub 2011 May 11.
3
Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery.通过剂量控制的 mRNA 递送避免转座酶的细胞毒性。
嵌合抗原受体T细胞(CAR-T)产品中使用的逆转录病毒载体设计、风险管理及未来展望。
MedComm (2020). 2025 Jan 24;6(2):e70067. doi: 10.1002/mco2.70067. eCollection 2025 Feb.
4
Pseudotyped Viruses: A Useful Platform for Pre-Clinical Studies Conducted in a BSL-2 Laboratory Setting.假型病毒:在生物安全二级(BSL-2)实验室环境中进行临床前研究的有用平台。
Biomolecules. 2025 Jan 15;15(1):135. doi: 10.3390/biom15010135.
5
The Furin Protease Dependence and Antiviral GBP2 Sensitivity of Murine Leukemia Virus Infection Are Determined by the Amino Acid Sequence at the Envelope Glycoprotein Cleavage Site.Furin 蛋白酶依赖性和抗病毒 GBP2 敏感性决定了小鼠白血病病毒感染的包膜糖蛋白切割位点的氨基酸序列。
Int J Mol Sci. 2024 Sep 16;25(18):9987. doi: 10.3390/ijms25189987.
6
Smoldering oncolysis by foamy virus carrying CD19 as a CAR target escapes CAR T detection by genomic modification.携带作为嵌合抗原受体(CAR)靶点的CD19的泡沫病毒介导的潜伏性肿瘤溶解通过基因组修饰逃避CAR T细胞检测。
Mol Ther Oncol. 2024 Jul 25;32(3):200852. doi: 10.1016/j.omton.2024.200852. eCollection 2024 Sep 19.
7
Advanced Therapies for Human Immunodeficiency Virus.人类免疫缺陷病毒的先进治疗方法。
Med Sci (Basel). 2024 Jul 18;12(3):33. doi: 10.3390/medsci12030033.
8
Viral and Non-Viral Systems to Deliver Gene Therapeutics to Clinical Targets.病毒和非病毒系统将基因治疗递送至临床靶标。
Int J Mol Sci. 2024 Jul 4;25(13):7333. doi: 10.3390/ijms25137333.
9
Reduced vacuolar ATPase protects mice from Friend virus infection - an unintended but instructive effect in Hif-2afl mice.溶酶体 ATP 酶减少可保护小鼠免受 Friend 病毒感染 - 在 Hif-2afl 小鼠中这是一种意外但有启发性的作用。
J Cell Sci. 2024 Jun 15;137(12). doi: 10.1242/jcs.261893. Epub 2024 Jun 28.
10
A review on Gaucher disease: therapeutic potential of β-glucocerebrosidase-targeted mRNA/saRNA approach.戈谢病综述:靶向β-葡萄糖脑苷脂酶的mRNA/saRNA疗法的治疗潜力
Int J Biol Sci. 2024 Mar 17;20(6):2111-2129. doi: 10.7150/ijbs.87741. eCollection 2024.
Nucleic Acids Res. 2011 Sep 1;39(16):7147-60. doi: 10.1093/nar/gkr384. Epub 2011 May 23.
4
Polyclonal fluctuation of lentiviral vector-transduced and expanded murine hematopoietic stem cells.慢病毒载体转导和扩增的鼠造血干细胞的多克隆波动。
Blood. 2011 Mar 17;117(11):3053-64. doi: 10.1182/blood-2010-08-303222. Epub 2011 Jan 19.
5
The Gag cleavage product, p12, is a functional constituent of the murine leukemia virus pre-integration complex.Gag 切割产物 p12 是鼠白血病病毒前整合复合物的功能性成分。
PLoS Pathog. 2010 Nov 11;6(11):e1001183. doi: 10.1371/journal.ppat.1001183.
6
Identification of hematopoietic stem cell-specific miRNAs enables gene therapy of globoid cell leukodystrophy.鉴定造血干细胞特异性 miRNAs 可实现球样细胞脑白质营养不良的基因治疗。
Sci Transl Med. 2010 Nov 17;2(58):58ra84. doi: 10.1126/scitranslmed.3001522.
7
Stem-cell gene therapy for the Wiskott-Aldrich syndrome.Wiskott-Aldrich 综合征的干细胞基因治疗。
N Engl J Med. 2010 Nov 11;363(20):1918-27. doi: 10.1056/NEJMoa1003548.
8
Gene therapy of chronic granulomatous disease: the engraftment dilemma.慢性肉芽肿病的基因治疗:植入困境。
Mol Ther. 2011 Jan;19(1):28-35. doi: 10.1038/mt.2010.232. Epub 2010 Nov 2.
9
The ethics of gene therapy: balancing the risks.基因治疗的伦理:权衡风险
Curr Opin Mol Ther. 2010 Oct;12(5):578-85.
10
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia.基因治疗人类β-地中海贫血后实现输血独立性和 HMGA2 激活。
Nature. 2010 Sep 16;467(7313):318-22. doi: 10.1038/nature09328.